![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, November 29, 2018 10:22:11 AM
This is where the leadership is WEAK! why reinvent the wheel?
FDA has undeniably mistaken this little company as their punching bag for WAY TOO LONG. FDA attorneys at Goodwin Procter are heavyweights. At least have them review what Sree is preparing prior to another submission.
I think its OBVIOUS that the FDA is now in PROTECTION MODE, maybe the big pharma companies are expressing more concern now that Bayer / scholls is in the mix, and a top 5 medical company is at the table (dont know who).
This may drag on for who knows how long, until you bring in professionals that no how to deal with the FDA BS!
Just my 2 cents
My comments above are simply my opinion and nothing more.
I'm enthusiastic at times however I am NOT a professional trader.
Please contact a financial consultant for investment advice.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM